CN109453168A - 一种四氢-β-咔啉衍生物的抗口腔癌用途 - Google Patents
一种四氢-β-咔啉衍生物的抗口腔癌用途 Download PDFInfo
- Publication number
- CN109453168A CN109453168A CN201811594583.XA CN201811594583A CN109453168A CN 109453168 A CN109453168 A CN 109453168A CN 201811594583 A CN201811594583 A CN 201811594583A CN 109453168 A CN109453168 A CN 109453168A
- Authority
- CN
- China
- Prior art keywords
- carcinoma
- mouth
- tetrahydro
- beta
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811594583.XA CN109453168B (zh) | 2018-12-25 | 2018-12-25 | 一种四氢-β-咔啉衍生物的抗口腔癌用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811594583.XA CN109453168B (zh) | 2018-12-25 | 2018-12-25 | 一种四氢-β-咔啉衍生物的抗口腔癌用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109453168A true CN109453168A (zh) | 2019-03-12 |
CN109453168B CN109453168B (zh) | 2021-01-12 |
Family
ID=65614550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811594583.XA Active CN109453168B (zh) | 2018-12-25 | 2018-12-25 | 一种四氢-β-咔啉衍生物的抗口腔癌用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109453168B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111281870A (zh) * | 2020-03-19 | 2020-06-16 | 郑州大学第一附属医院 | 一种抑制口腔癌细胞侵袭转移的药物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102424681A (zh) * | 2011-10-24 | 2012-04-25 | 华东师范大学 | 酰基四氢-β-咔啉类化合物及其衍生物、用途及其制备方法 |
-
2018
- 2018-12-25 CN CN201811594583.XA patent/CN109453168B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102424681A (zh) * | 2011-10-24 | 2012-04-25 | 华东师范大学 | 酰基四氢-β-咔啉类化合物及其衍生物、用途及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111281870A (zh) * | 2020-03-19 | 2020-06-16 | 郑州大学第一附属医院 | 一种抑制口腔癌细胞侵袭转移的药物 |
CN111281870B (zh) * | 2020-03-19 | 2022-11-25 | 郑州大学第一附属医院 | 一种抑制口腔癌细胞侵袭转移的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN109453168B (zh) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Constantinescu et al. | Anticancer activity of natural and synthetic chalcones | |
CN102958523B (zh) | 使用具有激酶抑制作用的组合的抗肿瘤剂 | |
Aswathy et al. | Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives | |
CN109453168A (zh) | 一种四氢-β-咔啉衍生物的抗口腔癌用途 | |
CN101652138B (zh) | 1-取代芳基-2(1h)-吡啶酮化合物的新医药用途 | |
CN103263433A (zh) | 6-姜烯酚增强胰腺癌对吉西他滨化疗敏感性及其复方药物 | |
CN106496052A (zh) | 一种査尔酮类化合物及其制备方法和应用 | |
CN101780066B (zh) | 异硫氰酸酯在制备防治肿瘤侵袭转移药物的用途 | |
CN102503888A (zh) | 2-芳基-1,3-异喹啉二酮类抗肿瘤化合物及其合成方法和用途 | |
CN110882238A (zh) | 一种桑辛素n在制备抗肿瘤药物中的应用 | |
CN109394769A (zh) | 一种嘧啶衍生物的抗甲状腺癌用途 | |
CN109453175A (zh) | 一种嘧啶衍生物在抗甲状腺癌中的应用 | |
CN109364081A (zh) | 一种嘧啶衍生物用于治疗甲状腺癌的用途 | |
CN109432099A (zh) | 一种嘧啶衍生物在治疗甲状腺癌方面的应用 | |
CN101120945B (zh) | 8-芳胺基-3H-咪唑[4,5-g]喹唑啉类衍生物的用途 | |
CN109260194A (zh) | 白花前胡甲素在缓解抗肿瘤药物顺铂所致肾毒性中的应用 | |
CN109432095A (zh) | 一种噻唑啉衍生物的医药用途 | |
CN106727535B (zh) | 一种含有紫杉醇的抗癌药物组合物 | |
Haseli et al. | Synergistic anticancer effects of crocin combined with deuterium-depleted water on HT-29 cells | |
CN109498624A (zh) | 一种噻唑啉衍生物的抗癌医药用途 | |
CN105311028B (zh) | 白藜芦醇基荜茇酰胺类似物在医药中的用途 | |
CN109364092A (zh) | 一种白鹤藤碱的新用途 | |
CN103784471A (zh) | 一种抗肿瘤的药物组合物 | |
CN109432118A (zh) | 白鹤藤碱在生物医药中的应用 | |
CN109223742A (zh) | 联合辛伐他汀与二甲双胍的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201223 Address after: 510000 Building 1, No.6 Dongbo Road, Guangzhou Economic and Technological Development Zone, Guangdong Province Applicant after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Address before: 211198 18 Jiangning Science Park, Nanjing, Jiangsu. Applicant before: NANJING GAISIFU MEDICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221108 Address after: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Patentee after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Patentee after: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Patentee after: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Patentee after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Patentee after: Euphorbia Biological Medicine Co.,Ltd. Address before: 510000 Building 1, No.6 Dongbo Road, Guangzhou Economic and Technological Development Zone, Guangdong Province Patentee before: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. |